Skip to main content
. 2016 Jan 11;73(6):1209–1224. doi: 10.1007/s00018-015-2117-6

Table 2.

Drug sensitivity or resistance to ALK mutations

ALK inhibitor Crizotinib Ceretinib Alectinib PF-06463922
Resistance mutation
G1123S Resistant [113] Sensitive [113]
1151Tins Resistant [79, 90] Resistant [90] Resistant [79] Sensitive [87]
L1152P/R Resistant [90] Resistant [90] Sensitive [114] Sensitive [87]
C1156Y/T Resistant [90] Resistant [90] Sensitive [87] Sensitive [87]
I1171T/N Resistant [90] Sensitive [90, 115, 116] Resistant [115, 116] Sensitive [87]
F1174L/C Resistant [90] Resistant [90] Sensitive [115] Sensitive [87]
V1180L Resistant [115] Sensitive [115] Resistant [115] Sensitive [87]
L1196M Resistant [78, 79, 83] Sensitive [90] Sensitive [87] Sensitive [87]
G1202R Resistant [79, 90] Resistant [84, 90] Resistant [79] Sensitive [72, 87]
S1206Y Resistant [79, 90] Sensitive [90] Sensitive [79] Sensitive [87]
G1269A/S Resistant [90] Sensitive [90] Sensitive [114] Sensitive [87]